Know Your Genes, Take Control of Your Health
Did you know Prostate cancer is the leading cause of cancer among African American men?
- All African American men are at high-risk of being diagnosed with and dying from prostate cancer1
- Approximately 1 out of every 5 African American men will be diagnosed with the disease1
- Black men are diagnosed at a rate 77% higher than white men and die at a 120% higher rate1
Genetic testing for prostate cancer looks at your DNA to personalize cancer treatment regardless of where you are in your journey.
Benefits of Genetic Testing
New life-sustaining treatment options are available for men with prostate cancer and a DNA mutation. Genetic testing is the only way to know if you qualify.
Certain DNA mutations increase the likelihood of a more aggressive cancer and this information should be used when considering active surveillance. 2, 3
Genetic testing informs family members (blood related) if they are at an increased risk for developing certain cancers.
How it Works
Request Your Myriad Genetic Test Kit
Kits are mailed directly to your house and generally arrive in 5-7 days.
Work with Provider to Obtain Sample
Remote testing options are available and Myriad is committed to help you understand your options.
Your Genes are Analyzed at Our State-of-the-Art Facility
Myriad looks at your unique genetic information using the latest in sequencing technology.
Results available in around 2 weeks
Once results are available, they are sent securely to your doctor’s office. Your doctor will then help you understand your results and own your health.
Frequently Asked Questions
- 97% of people have coverage for genetic testing, with 3/4 of all patient’s paying $0. For those with an out-of-pocket cost – the average is <$60.
- Myriad offers broad payment plans and financial assistance if financial and medical criteria are met.
Toll free: 855-469-7765
Submit the form below to receive your Testing Kit
1. American Cancer Society. Cancer Facts & Figures for African Americans 2019-2021.
2. NCCN Guidelines Version 2.2021 Prostate Cancer
3. Gomella LG et al. Introduction to the 2019 Philadelphia Prostate Cancer Consensus Program: Implementation of Genetic Testing for Inherited Prostate Cancer. Can J Urol. 2019;26(5 Suppl 2):1-4